Inside the Lab Where Scientists Explored Bioavailable Natural Compounds
Malaria is one of the most studied infectious diseases on the planet, and research groups continue searching for new ways to support the body’s defenses. One study examined how MyCell®-enhanced botanicals behaved when tested on malaria-infected red blood cells — and the results highlight the surprising power of bioavailability.
What the Researchers Wanted to Understand
Scientists exposed malaria-infected cells to natural compounds that have historically shown antimicrobial potential, including:
-
Artemisinin
-
Curcumin
-
Vitamin C
-
Boswellia
-
Ginger
Some were delivered in their “free” (non-encapsulated) form. Others were delivered using MyCell® technology, which transforms fat-soluble botanicals into water-soluble micro-droplets for improved absorption.
What the Study Found
Encapsulated curcumin showed dramatically higher activity
Curcumin in its free form showed moderate antimicrobial properties — but when encapsulated using MyCell® technology, its potency increased significantly.
Vitamin C behaved differently when made water-soluble
Free vitamin C did not have a measurable effect on infected cells.
But MyCell® vitamin C showed activity that only became measurable once it was made highly bioavailable.
Artemisinin remained a strong performer
As one of the most researched natural compounds related to malaria, artemisinin continued to show notable results.
Taken together, the study demonstrated a clear pattern:
Bioavailability influences biological activity — dramatically.
What This Means for Future Innovation
The most important takeaway from this research is not about malaria specifically, but about delivery technology.
Natural compounds may behave very differently depending on:
-
how they are delivered
-
how quickly they reach cells
-
how stable they are in the body
-
how easily they cross biological membranes
MyCell® technology enables botanicals to remain stable, water-soluble, and readily absorbed — which may open new possibilities for future research in many fields.
While Mitacell products are not designed to treat malaria, this study demonstrates the importance of delivery systems in the broader scientific landscape.
Disclaimer:
This article summarizes laboratory research involving MyCell®-enhanced compounds. Mitacell products are not intended to diagnose, treat, cure, or prevent malaria or any disease. Always consult a healthcare professional for medical guidance.